Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer.
Jae-Seung KangSu Young HongYoungmin HanHee Ju SohnMirang LeeYoon Hyung KangHyeong Seok KimHyeong Seok KimWooil KwonJin-Young JangPublished in: Annals of surgical treatment and research (2021)
Serum CEA and CA 19-9 levels are not suitable for screening GBC patients from controls. New promising biomarkers with higher sensitivity should be explored.